Skip to main content

Web Exclusives

Meeting Highlights
Lung Cancer, ASCO Highlights
Atezolizumab Extends Disease-Free Survival in PD-L1−Positive Early-Stage NSCLC
Phoebe Starr
Phoebe Starr
Read More
Meeting Highlights
Prostate Cancer, ASCO Highlights
¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer
Phoebe Starr
Phoebe Starr
Read More
Cholangiocarcinoma
A Watershed Moment for the Cholangiocarcinoma Community
Stacie C. Lindsey
Stacie C. Lindsey
Read More
FDA Updates
FDA Approves Darzalex Faspro plus Pomalyst and Dexamethasone for Multiple Myeloma
Read More
FDA Updates
FDA Approves Avapritinib for Advanced Systemic Mastocytosis
Read More
FDA Updates
Pembrolizumab plus Lenvatinib Combination Receives Regular Approval for Advanced Endometrial Carcinoma
Read More
FDA Updates
Padcev Receives Regular FDA Approval for Locally Advanced or Metastatic Urothelial Cancer
Read More
FDA Updates
FDA Alert: Pepaxto (Melphalan Flufenamide) Associated with Increased Risk of Death in Postmarketing Clinical Trial
Read More
Breast Cancer, FDA Updates
FDA Approves Margenza for Treatment of Metastatic HER2-Positive Breast Cancer
Read More
Cholangiocarcinoma
Emerging Molecular Targets in Cholangiocarcinoma: IDH1, HER2, BRAF, and Beyond
Read More
Page 6 of 43
Results 51 - 60 of 430